UNSPSC 51282810: Metronidazole benzoate

This classification denotes a trichomonacide agent and protein synthesis inhibitor with the molecular formula C13H13N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A355C835XC, chemically known as 2-(2-methyl-5-nitroimidazol-1-yl)ethyl benzoate, but more generally known as metronidazole benzoate, which bears US NIH Compound Identifier 4173. European Medicines Agency schedules metronidazole benzoate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08922MIG.

Most nations, for tariff purposes, schedule metronidazole benzoate under HS 29332990. Metronidazole benzoate bears US NLM identifiers UMLS ID C0353490 and NCI Concept Code C87387. SMILES: CC1NCC(N1CCOC(=O)C2CCCCC2)[N+](=O)[O-].

UNSPSC 51282810 Metronidazole benzoate, a Commodity code, shows minimal recent state and local procurement activity directly aligned with its nominal scope. The recent opportunities posted under this code involve pharmaceutical procurement more broadly — naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies, and generic pharmaceuticals and OTC products — but do not center on metronidazole benzoate specifically. State and local governments posting under this code are principally county health departments and state health agencies seeking to source medications and medical supplies through competitive bidding, cooperative purchasing vehicles, and request for information processes rather than procurement of metronidazole benzoate as a standalone product line.

The issuing bodies include Seminole County, Florida (health procurement), the Texas Health and Human Services Commission (pharmacy benefit management), the City of Tampa Fire Department (emergency medical supplies), and the Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities across multiple states including Oregon. Geographically, recent activity spans Florida, Texas, Minnesota, and Oregon, with cooperative purchasing extending across participating state and local government members. Representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for naloxone and drug deactivation systems with quarterly deliveries; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies with an estimated contract value of $700,000 and a sheltered-market set-aside for certified Small Local Business Enterprises; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, proposals due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers. The code itself does not generate standalone procurement signals for metronidazole benzoate; vendors should verify whether opportunities tagged under this code match their product offering before pursuing.